A supplemental biologics application for AstraZeneca’s FluMist Quadrivalent is currently being reviewed by the FDA. If approved, FluMist would be the first needle-free, nasal spray influenza vaccine available to be self-administered by patients or caregivers.
A year after discovering that flu vaccines decrease the risk of Alzheimer's disease by 40%, the same research team found that several other common vaccines also provide protective benefits.
A team from the University of Geneva has identified how the influenza A virus manages to penetrate cells to infect them.
Researchers from Brigham and Women’s Hospital, in collaboration with Danish researchers, have identified two types of electronic letters that resulted in modest but “statistically significant” increases in influenza vaccination rates,
Read More
The method, based on triplex-forming probe technology, opens up new options for detecting viruses like SARS-CoV-2, influenza A, or RSV.
Read More
Seizure risks, a needle-free vaccine patch, and a compound that may limit flu replication—here are five flu stories you should check out this week.
Read More
The US FDA issued an emergency use authorization for the Lucira COVID-19 & Flu Test, the first over-the-counter (OTC) at-home diagnostic test that can differentiate and detect influenza A and B and SARS-CoV-2.
Read More
Researchers say the discovery is essential to developing future therapies to limit viral infection and improve the health of patients with chronic lung disease.
Read More
The preclinical research demonstrated the ability of Infectimune to significantly boost CD4 T cell activity, suggesting that Infectimune-based vaccines could provide durable protection against seasonal flu and potentially emerging pandemic flu.
Read More
The trial will assess the safety, tolerability, and immunogenicity of the IIV4 candidate in approximately 150 healthy participants, aged 18 to 50.
Read More
The 40-month project may culminate in a prototype bivalent vaccine candidate that is effective against both the H5N1 and H7N9 strains of influenza, according to Access to Advanced Health Institute.
Read More
Researchers have discovered a compound that inhibits the body’s own methyltransferase MTr1, which limits the replication of influenza viruses and may lead to the development of new treatments for the flu.
Read More
A poll of 1,234 adults aimed to determine how many households had recently been impacted by RSV, COVID-19 or the flu and to gauge their concern about whether they’re worried about becoming ill with one of the viruses.
Read More
BD received FDA emergency use authorization for its new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and respiratory syncytial virus (RSV).
Read More
The American Thoracic Society is partnering with three health systems in the US to improve adult vaccination rates.
Read More